Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Rejnmark

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 22, 2022
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway TrialAliya A Khan, Mishaela R Rubin, Peter Schwarz, et al.
Advances in Therapy|May 1, 2024
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway TrialLars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
Nature Reviews. Nephrology|February 5, 2025
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemiaDieter Haffner, Francesco Emma, Lothar Seefried, et al.
Nature Reviews. Nephrology|January 15, 2025
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemiaDieter Haffner, Francesco Emma, Lothar Seefried, et al.
The American Journal of Clinical Nutrition|June 6, 2018
Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trialsKarin Ma Swart, Paul Lips, Ingeborg A Brouwer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 21, 2026
Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-TrialLars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
European Journal of Endocrinology|July 25, 2025
rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomesMaria Luisa Brandi, Tamara Vokes, Natasha M Appelman-Dijkstra, et al.
European Journal of Endocrinology|December 4, 2021
European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid DisordersJens Bollerslev, Lars Rejnmark, Alexandra Zahn, et al.
Frontiers in Endocrinology|August 2, 2018
Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance PaperStefan Pilz, Winfried März, Kevin D Cashman, et al.
Nutrients|January 6, 2019
Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European CohortsThor Aspelund, Martin R Grübler, Albert V Smith, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 22, 2022
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway TrialAliya A Khan, Mishaela R Rubin, Peter Schwarz, et al.
Advances in Therapy|May 1, 2024
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway TrialLars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
Nature Reviews. Nephrology|February 5, 2025
Publisher Correction: Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemiaDieter Haffner, Francesco Emma, Lothar Seefried, et al.
Nature Reviews. Nephrology|January 15, 2025
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemiaDieter Haffner, Francesco Emma, Lothar Seefried, et al.
The American Journal of Clinical Nutrition|June 6, 2018
Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trialsKarin Ma Swart, Paul Lips, Ingeborg A Brouwer, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 21, 2026
Sustained Improvement in Renal Function with Palopegteriparatide in Adults with Chronic Hypoparathyroidism: 2-Year Results from the Phase 3 PaTHway-TrialLars Rejnmark, Elvira O Gosmanova, Aliya A Khan, et al.
European Journal of Endocrinology|July 25, 2025
rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomesMaria Luisa Brandi, Tamara Vokes, Natasha M Appelman-Dijkstra, et al.
European Journal of Endocrinology|December 4, 2021
European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid DisordersJens Bollerslev, Lars Rejnmark, Alexandra Zahn, et al.
Frontiers in Endocrinology|August 2, 2018
Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance PaperStefan Pilz, Winfried März, Kevin D Cashman, et al.
Nutrients|January 6, 2019
Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European CohortsThor Aspelund, Martin R Grübler, Albert V Smith, et al.
Pageof 27